KRT19 and breast neoplasm: Thus, availability of K5+/K19+ and K5+/K19− mammary stem/progenitor cell lines generated in our laboratory provides a unique opportunity to assess their ability to serve as cells of origin for breast tumors and the impact of cell type versus oncogenes in tumor associated characteristics.